EB-1A · Extraordinary Ability · Profession Guide

EB-1A for Chemists and materials scientists: Kazarian Criteria & AAO Patterns

How chemists and materials scientists satisfy the Kazarian two-step analysis: which of the ten regulatory criteria are most accessible for this profession, and what final-merits evidence has cleared AAO scrutiny.

Based on 6,362 real USCIS AAO decisions · Last updated May 2026

Short answer

EB-1A requires chemists and materials scientists to meet at least 3 of the 10 Kazarian regulatory criteria and then clear a final-merits analysis that the petitioner has sustained national or international acclaim. EB-1A denials commonly cite lab-scale work without record evidence of scale-up, licensing, or regulatory adoption.

Most accessible Kazarian criteria for chemists and materials scientists

The regulation requires that you meet at least 3 of 10 criteria from 8 CFR § 204.5(h)(3). Below are the criteria most commonly satisfied in EB-1A petitions by chemists and materials scientists, with profession-specific evidence patterns.

  1. 1

    Original contributions of major significance

    Patents on novel synthetic routes, formulations, or materials with industry licensing or pilot-scale deployment evidence.

  2. 2

    Authorship of scholarly articles

    Refereed publications in JACS, Nature Chem, Advanced Materials, Nature Materials, with independent citations.

  3. 3

    Service as a judge of others' work

    Editorial-board service, ACS / RSC peer review, DOE / NSF grant-review service.

  4. 4

    Original contributions — alternate framing

    Methods adopted as industry standards (USP / NF monographs, ASTM standards) carry significant weight.

Final-merits framing under Kazarian step 2

Final-merits framing for chemists tends to favor petitioners whose work has crossed from lab to industrial / regulatory adoption. Patents-with-licenses and standards-committee work consistently outperform publication-only profiles.

Why EB-1A petitions by chemists and materials scientists fail at AAO

EB-1A denials commonly cite lab-scale work without record evidence of scale-up, licensing, or regulatory adoption. Patent licenses or pilot-plant deployment evidence are the cleanest counter.

For context: across all professions, 5.9% of NIW appeals are approved at the AAO level. EB-1A appeals follow similar dynamics — most denials are at first-pass USCIS, and AAO data reveals which arguments fail at the highest scrutiny level.

Build your EB-1A petition with profession-specific framing

Our $99 EB-1A Petition Builder generates a Kazarian-framework petition letter section by section, with criterion-by-criterion evidence framing tailored to your profile and references to similar approved AAO cases in our 6,362-decision corpus.

One-time payment, no subscription. Greenway AI is a data + document-generation platform, not a law firm; nothing here is legal advice.